Navigation Links
American Society for Microbiology honors Thomas E. Wellems

Washington, DCSeptember 13, 2007 The 2007 American Society for Microbiology (ASM) sanofi-aventis U.S. Award will be presented to Thomas E. Wellems, M.D., Ph.D., Chief, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland. Supported by an unrestricted grant from sanofi-aventis U.S., this award honors outstanding accomplishment in antimicrobial chemotherapy.

Dr. Wellems has had an outstanding career in infectious disease, most of which he has devoted to the study of malaria and its treatment. Resistance to chloroquine, a popular malaria vaccine that was very successful in the 1950s, has dramatically increased death rates from malaria in Africa and Asia. Dr. Wellems was able to identify the chloroquine transporter and develop a diagnostic test, which has made serious impacts on malaria treatment. Among other important findings, Wellems has published in more than 100 papers. He has received many honors, including the Bailey K. Ashford Medal for distinguished work in tropical medicine and the LePrince A. Medal for outstanding work in the field of malariology, both from the American Society of Tropical Medicine and Hygiene; the Lincei Golgi Medal, Academia Nazionale dei Lincei, Rome; and the Howard Taylor Rickets Awards Lecture, The University of Chicago. He is also a Fellow of the American Academy of Microbiology.

Dr. Wellems received two B.S. degrees in Physics and Chemistry from New Mexico Institute of Mining and Technology, and an M.D. and Ph.D. in Biophysics in the University of Chicagos Medical Scientist Training Program. He completed his residency at the Hospital of the University of Pennsylvania, and his fellowship training at the Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases.


Contact: Peggy McNult
American Society for Microbiology

Page: 1

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research
Post Your Comments:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
(Date:6/23/2016)... 2016 Andrew D ... Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: